Orchestrating mitochondrial catastrophe: Mechanistic insights and therapeutic frontiers of cuproptosis in precision pharmacology
Current Opinion in Pharmacology · مجلد 88 · 102629-102629
Research outputs
مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.
5 مُخرَج نتائج البحث عن «Frontier»
Current Opinion in Pharmacology · مجلد 88 · 102629-102629
ChemistrySelect · مجلد 11 (2)
ABSTRACT This research explores the capacity of phenyl styryl ketone derivatives to inhibit monoamine oxidase B (MAO‐B), a key enzyme associated with neurodegenerative disorders. From frontier molecular orbital (FMO) studies, reactivity parameters of the drug candidates were found out. Ligands were submitted to absorption, digestion, metabolism, excretion, and toxicity (ADMET) analysis to ensure their potential drugability and safety. To understand the electronic description of ligand interaction, natural bond orbital (NBO) analysis was conducted, and the presence of heteroatoms was proven crucial. The reduced density gradient (RDG) studies, together with molecular electrostatic surface potential (MESP) analysis, were able to provide the ligand's active sites and nature of interaction. Docking studies were conducted to study the interaction between the protein (P) and ligand (L) at the MAO‐B catalytic region, alongside a comparison with safinamide, a recognized MAO‐B inhibitor. Molecular dynamics (MD) simulations were utilized to examine the protein–ligand complex (PLC). The molecular mechanics Poisson–Boltzmann surface area (MM‐PBSA) method was applied to predict the binding affinity and interaction. We also analyzed structural stability, solvation, and decomposition. Of the four ligands examined, CHA_1.4 is found to be the most efficient. The contact map method was useful in identifying the key amino acids; in all the complexations we have considered, TYR398 has interacted most with the drug candidates. The finding was in agreement with the decomposition profile of the PLC. For the principal component analysis (PCA), topology formats and 100 ns MD trajectories are used to learn more about how proteins fold. Replicates were also done to validate the reported study and are represented as box‐whisker plots. The study's findings provide valuable insights for the development of new MAO‐B inhibitors.
Journal of Drug Delivery Science and Technology · مجلد 114 · 107448-107448
Drug Development Research · مجلد 86 (5) · e70131-e70131
Since lung cancer accounts for approximately 20% of cancer-related fatalities globally, it is one of the most common and deadly cancers, necessitating the discovery of innovative, potent, and less toxic treatment agents as imperative. Opportunistically, phytoflavonoids (PFs), a specific class of phytochemicals, display promising anticancer activity through their multimodal apoptosis-inducing properties. Based on existing evidence, the present study employs an integrative multi-omics approach to assess the target-specific binding efficacy and drug-ability outlines of PFs against lung cancer. We selected two of the most likely lung cancer targets using the core part of PFs: carbonic anhydrase IX (PDB ID: 3DAZ) and poly(A) binding protein cytoplasmic 1 (PDB ID: 3KUJ). Another two key targets, glutathione S-transferase P1 (PDB ID: 3GSS) and 17β-hydroxysteroid dehydrogenase 1 (HSD17B1, 3HB4), were also included in our study based on recent literature. The potency of 66 PFs against four targets was assessed through a molecular docking study using PyRx 0.8-AutoDock 4.2 software. PF15, PF43, PF6, and PF26 were the lead candidates. Further, physicochemical profiles through standard Lipinski rule of five parameters and toxicity and drug-ability profiles suggested that PF43 (naringenin) is the most ideal lead candidate among them. Molecular dynamics (MD) simulation studies were performed at 200 ns to observe the kinetic behaviors of CA9-PF43 and CA9-U-1014 docking complexes along with the calculated free energy through the MM/PBSA method. From both analyses, PF43 showed higher stability and lower free energy, expressing its potency over the standard drug. We also investigated the structure-activity relationship and frontier molecular orbitals to highlight the drug chemistry of lead PFs. The integrative multi-omics investigation suggested that using PF43 for lung cancer treatment could increase the chances of experimental success. Overall, the systematic computational analyses provide a platform for lead identification and pave the way for precision phytotherapy in current drug discovery.
International Conference on New Frontiers in Communication, Automation, Management and Security (ICCAMS) · 1-7
This research paper presents a blockchain-based approach for fault detection and secure communication in vehicular ad hoc networks (VANETs). VANETs are an emerging technology that allows vehicles to communicate with each other and with the surrounding infrastructure to improve safety and efficiency on the roads. However, the decentralized and dynamic nature of VANETs makes them vulnerable to various types of attacks, including false data injection and communication interference. To address these challenges, the proposed approach utilizes blockchain technology to ensure the integrity and authenticity of data exchanged among vehicles and the infrastructure. The system also includes a fault detection mechanism that can detect and isolate faulty vehicles to prevent them from disrupting the communication network. However, VANETs are distinct from conventional mobile ad hoc networks due to the high mobility of vehicles, which creates dynamic network environments and frequent link interruptions that result in message loss. A hierarchical defect detection method based on dead reckoning is proposed to address these issues. The technique uses the dead reckoning model to predict the transmission time of pulse messages and builds a hierarchical detection architecture with Roadside Units (RSUs) functioning as static nodes. This architecture enhances the efficacy of VANET fault detection. The proposed method was validated by NS-2 simulations, demonstrating superior performance in terms of detection speed, accuracy, and detection burden compared to the baseline fault detection method.